Acadia Pharmaceuticals (NASDAQ: ACAD) aspires to become a big player in the neuroscience market. Eli Lilly (NYSE: LLY) already is one. But aside from their common interest in this therapeutic category, there's little in common between these two drugmakers.Investors considering buying shares of Acadia or Lilly have a stark contrast -- beaten-down biotech, or relatively boring big pharma.
Similar Stories to Better Buy: Acadia Pharmaceuticals Vs. Eli Lilly on Bing News
newsfeedback@fool.com (Keith Speights), The Motley Fool
Fri, 07/13/2018 - 5:17am
BING NEWS:
- ACADIA Pharmaceuticals (ACAD) Receives a Hold from Oppenheimer
In a report released today, Jay Olson from Oppenheimer maintained a Hold rating on ACADIA Pharmaceuticals (ACAD – Research Report), with ...
11/8/2024 - 6:38 am | View Link - Acadia Pharmaceuticals Sees Revenue Growth and Strategic Advances
ACADIA Pharmaceuticals Inc. ( (ACAD) ) has released its Q3 earnings. Here is a breakdown of the information ACADIA Pharmaceuticals Inc.
11/7/2024 - 12:26 am | View Link - Acadia sells speedy drug review voucher for $150M
The selling price is an indication that the FDA’s planned sunsetting of the rare pediatric disease voucher program may be pushing values higher, according to one analyst.
11/6/2024 - 3:45 am | View Link - Acadia Pharmaceuticals Enters Into an Agreement to Sell its Rare Pediatric Disease Priority Review Voucher for $150 Million
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it entered into a definitive asset purchase agreement to sell its Rare Pediatric Disea ...
11/5/2024 - 12:05 pm | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more